Immediate Office |
|
|
Robin Robinson, Ph.D. Director |
|
|
|
Carol D. Linden, Ph.D. Principal Deputy Director |
|
|
Richard J. Hatchett, M.D. Chief Medical Officer & Deputy Director for Strategic Sciences |
|
|
|
|
Influenza and Emerging Diseases Division |
|
|
Robert (Bob) Huebner, Ph.D. Acting Director |
|
|
|
R. Thomas Warf, M.S. Product Process Development Analysis |
Division of Chemical, Biological, Radiological, and Nuclear (CBRN) Countermeasures |
|
|
Gerald R. Kovacs, Ph.D. Director |
|
|
|
Gary L. Disbrow, Ph.D. Deputy Director |
Strategic Science and Technology Division |
|
|
Jonathan Seals, Ph.D. Acting Director |
|
|
|
|
Regulatory and Quality Affairs Division |
|
|
Debra Yeskey, Pharm.D. Director |
|
|
|
|